MYD88 and cancer: Mutations across CH and cancer cases are also very similarly distributed along the gene in the case of MYD88 (with one dominant hotspot), but their distributions differ in IDH2. The pattern of mutations observed in these CH genes across the primary and metastasis cohorts resembles those obtained across the targeted cohort (Supp.